ENTRESTO
Film-coated tablet, 51mg + 49mg
RxActive license
Active substance (INN)
sacubitrilvalsartan
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength51mg + 49mg
PackagingUkupno 56 film tableta u blisteru (4x14) u kartonskoj kutiji
ManufacturerNovartis Farma SpA, Italy
Therapeutic groupCardiovascular system (C09DX04)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateMay 9, 2023
Analogs in Montenegro
20Other medicines with the same active substance
CO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgDIOVANRx
Film-coated tablet, 40mgDIOVANRx
Film-coated tablet, 80mgENTRESTORx
Granules in capsules for opening, 6mg/6mgENTRESTORx
Film-coated tablet, 26mg + 24mgENTRESTORx
Film-coated tablet, 103mg + 97mgENTRESTORx
Granules in capsules for opening, 16mg/15mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgSAKUBITRIL/VALSARTAN HFRx
Film-coated tablet, 49mg/51mgSAKUBITRIL/VALSARTAN HFRx
Film-coated tablet, 97mg/103mgSAKUBITRIL/VALSARTAN HFRx
Film-coated tablet, 24mg/26mgVALOMINDORx
Modified-release tablet, 160mg + 1.5mgVALOMINDORx
Modified-release tablet, 80mg + 1.5mgVALSACOMBIRx
Film-coated tablet, 160mg + 12.5mgVALSACOMBIRx
Film-coated tablet, 80mg + 12.5mgVALSACOMBIRx
Film-coated tablet, 160mg + 25mgSource: CInMED register